4DMedical Limited (ASX:4DX)

4DMedical Statistics

Total Valuation

4DMedical has a market cap or net worth of AUD 905.04 million. The enterprise value is 902.47 million.

Market Cap	905.04M
Enterprise Value	902.47M

Important Dates

The next estimated earnings date is Thursday, November 27, 2025.

Earnings Date	Nov 27, 2025
Ex-Dividend Date	n/a

Share Statistics

4DMedical has 500.02 million shares outstanding. The number of shares has increased by 25.66% in one year.

Current Share Class	500.02M
Shares Outstanding	500.02M
Shares Change (YoY)	+25.66%
Shares Change (QoQ)	-49.42%
Owned by Insiders (%)	3.65%
Owned by Institutions (%)	1.16%
Float	408.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	154.62
PB Ratio	14.09
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-30.01
EV / Sales	154.18
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-26.11

Financial Position

The company has a current ratio of 0.89, with a Debt / Equity ratio of 0.07.

Current Ratio	0.89
Quick Ratio	0.74
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.12
Interest Coverage	-188.80

Financial Efficiency

Return on equity (ROE) is -44.49% and return on invested capital (ROIC) is -41.63%.

Return on Equity (ROE)	-44.49%
Return on Assets (ROA)	-28.02%
Return on Invested Capital (ROIC)	-41.63%
Return on Capital Employed (ROCE)	-63.74%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	145
Asset Turnover	0.05
Inventory Turnover	0.49

Taxes

Income Tax	-87,118
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +311.36% in the last 52 weeks. The beta is 1.71, so 4DMedical's price volatility has been higher than the market average.

Beta (5Y)	1.71
52-Week Price Change	+311.36%
50-Day Moving Average	0.88
200-Day Moving Average	0.49
Relative Strength Index (RSI)	63.09
Average Volume (20 Days)	16,133,325

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, 4DMedical had revenue of AUD 5.85 million and -30.07 million in losses. Loss per share was -0.06.

Revenue	5.85M
Gross Profit	5.39M
Operating Income	-48.16M
Pretax Income	-30.16M
Net Income	-30.07M
EBITDA	-45.82M
EBIT	-48.16M
Loss Per Share	-0.06

Balance Sheet

The company has 6.88 million in cash and 4.31 million in debt, giving a net cash position of 2.57 million or 0.01 per share.

Cash & Cash Equivalents	6.88M
Total Debt	4.31M
Net Cash	2.57M
Net Cash Per Share	0.01
Equity (Book Value)	64.24M
Book Value Per Share	0.14
Working Capital	-2.19M

Cash Flow

In the last 12 months, operating cash flow was -34.48 million and capital expenditures -85,838, giving a free cash flow of -34.56 million.

Operating Cash Flow	-34.48M
Capital Expenditures	-85,838
Free Cash Flow	-34.56M
FCF Per Share	-0.07

Margins

Gross Margin	92.07%
Operating Margin	-822.76%
Pretax Margin	-515.20%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

4DMedical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.66%
Shareholder Yield	n/a
Earnings Yield	-3.32%
FCF Yield	-3.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

4DMedical has an Altman Z-Score of -0.76 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.76
Piotroski F-Score	1